Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies

Abstract Background The incidence of thyroid carcinoma is increasing all over the world. Some studies have suggested that the change of adipokines expression can induce thyroid carcinoma. However, other studies have come to the opposite conclusion. Therefore, we studied the relationship between adip...

Full description

Bibliographic Details
Main Authors: Junyu Zhao, Jing Wen, Shengnan Wang, Jinming Yao, Lin Liao, Jianjun Dong
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-020-07299-x
_version_ 1828791476041023488
author Junyu Zhao
Jing Wen
Shengnan Wang
Jinming Yao
Lin Liao
Jianjun Dong
author_facet Junyu Zhao
Jing Wen
Shengnan Wang
Jinming Yao
Lin Liao
Jianjun Dong
author_sort Junyu Zhao
collection DOAJ
description Abstract Background The incidence of thyroid carcinoma is increasing all over the world. Some studies have suggested that the change of adipokines expression can induce thyroid carcinoma. However, other studies have come to the opposite conclusion. Therefore, we studied the relationship between adipokines and thyroid carcinoma. Methods Databases—PubMed, Cochrane Library, SinoMed, CNKI, Wanfang, and clinical trial registries were searched. A meta-analysis was then performed through a fixed or random-effects model to calculate I values for heterogeneity analysis. Results Twenty-nine articles were finally included for analysis. The level of serum tumor necrosis factor-alpha (TNF-α) [standardized mean difference (SMD) =1.31, 95% confidence interval (95% CI): 0.35 to 2.28, I2 = 98%, P = 0.008] and the ratio of TNF-α immunoreactivity in tissues [odds ratios (OR) =6.36, 95% CI: 1.92 to 21.05, I2 = 66%, P = 0.002] in thyroid carcinoma are significantly higher than those in control. The serum interleukin-6 (IL-6) in patients with thyroid carcinoma is higher than that in control (SMD = 1.04, 95% CI: 0.40 to 1.67, I2 = 96%, P = 0.001). There is no significant difference of the ratio of IL-6 immunoreactivity in tissues between carcinoma and control (OR = 1.23, 95% CI: 0.62 to 2.43, I2 = 86%, P = 0.55). The ratio of leptin immunoreactivity in tissues is significantly associated with the risk of thyroid carcinoma (OR = 12.21, 95% CI: 3.36 to 44.40, I2 = 85%, P < 0.00001). However, after analyzing the expression level of serum adiponectin in three studies, no significant difference is found between thyroid carcinoma and the control (P = 0.81). Conclusions Adipokines (TNF-α, IL-6 and leptin) show a strong relationship between elevated concentrations (in serum and/or tissue) and thyroid carcinoma. However, the association between adiponectin and thyroid carcinoma needs further research.
first_indexed 2024-12-12T02:51:31Z
format Article
id doaj.art-d6a39af43396467aac004fd20b81395c
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-12T02:51:31Z
publishDate 2020-08-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-d6a39af43396467aac004fd20b81395c2022-12-22T00:40:53ZengBMCBMC Cancer1471-24072020-08-0120111310.1186/s12885-020-07299-xAssociation between adipokines and thyroid carcinoma: a meta-analysis of case-control studiesJunyu Zhao0Jing Wen1Shengnan Wang2Jinming Yao3Lin Liao4Jianjun Dong5Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan HospitalCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese MedicineDepartment of Endocrinology and Metabology, Shandong First Medical University & Shandong Academy of Medical SciencesDepartment of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan HospitalDepartment of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan HospitalDepartment of Endocrinology and Metabology, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong UniversityAbstract Background The incidence of thyroid carcinoma is increasing all over the world. Some studies have suggested that the change of adipokines expression can induce thyroid carcinoma. However, other studies have come to the opposite conclusion. Therefore, we studied the relationship between adipokines and thyroid carcinoma. Methods Databases—PubMed, Cochrane Library, SinoMed, CNKI, Wanfang, and clinical trial registries were searched. A meta-analysis was then performed through a fixed or random-effects model to calculate I values for heterogeneity analysis. Results Twenty-nine articles were finally included for analysis. The level of serum tumor necrosis factor-alpha (TNF-α) [standardized mean difference (SMD) =1.31, 95% confidence interval (95% CI): 0.35 to 2.28, I2 = 98%, P = 0.008] and the ratio of TNF-α immunoreactivity in tissues [odds ratios (OR) =6.36, 95% CI: 1.92 to 21.05, I2 = 66%, P = 0.002] in thyroid carcinoma are significantly higher than those in control. The serum interleukin-6 (IL-6) in patients with thyroid carcinoma is higher than that in control (SMD = 1.04, 95% CI: 0.40 to 1.67, I2 = 96%, P = 0.001). There is no significant difference of the ratio of IL-6 immunoreactivity in tissues between carcinoma and control (OR = 1.23, 95% CI: 0.62 to 2.43, I2 = 86%, P = 0.55). The ratio of leptin immunoreactivity in tissues is significantly associated with the risk of thyroid carcinoma (OR = 12.21, 95% CI: 3.36 to 44.40, I2 = 85%, P < 0.00001). However, after analyzing the expression level of serum adiponectin in three studies, no significant difference is found between thyroid carcinoma and the control (P = 0.81). Conclusions Adipokines (TNF-α, IL-6 and leptin) show a strong relationship between elevated concentrations (in serum and/or tissue) and thyroid carcinoma. However, the association between adiponectin and thyroid carcinoma needs further research.http://link.springer.com/article/10.1186/s12885-020-07299-xThyroid carcinomaAdipokinesTNF-αIL-6LeptinMeta-analysis
spellingShingle Junyu Zhao
Jing Wen
Shengnan Wang
Jinming Yao
Lin Liao
Jianjun Dong
Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies
BMC Cancer
Thyroid carcinoma
Adipokines
TNF-α
IL-6
Leptin
Meta-analysis
title Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies
title_full Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies
title_fullStr Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies
title_full_unstemmed Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies
title_short Association between adipokines and thyroid carcinoma: a meta-analysis of case-control studies
title_sort association between adipokines and thyroid carcinoma a meta analysis of case control studies
topic Thyroid carcinoma
Adipokines
TNF-α
IL-6
Leptin
Meta-analysis
url http://link.springer.com/article/10.1186/s12885-020-07299-x
work_keys_str_mv AT junyuzhao associationbetweenadipokinesandthyroidcarcinomaametaanalysisofcasecontrolstudies
AT jingwen associationbetweenadipokinesandthyroidcarcinomaametaanalysisofcasecontrolstudies
AT shengnanwang associationbetweenadipokinesandthyroidcarcinomaametaanalysisofcasecontrolstudies
AT jinmingyao associationbetweenadipokinesandthyroidcarcinomaametaanalysisofcasecontrolstudies
AT linliao associationbetweenadipokinesandthyroidcarcinomaametaanalysisofcasecontrolstudies
AT jianjundong associationbetweenadipokinesandthyroidcarcinomaametaanalysisofcasecontrolstudies